Abstract

Wearable devices equipped with inertial sensors enable objective gait assessment for persons with multiple sclerosis (MS), with potential use in ambulatory care or home and community-based assessments. However, gait data collected in non-controlled settings are often fragmented and may not provide enough information for reliable measures. This paper evaluates a novel approach to (1) determine the effects of the length of the walking task on the reliability of calculated measures and (2) identify digital biomarkers for gait assessments from fragmented data. Thirty-seven participants (37) diagnosed with relapsing-remitting MS (EDSS range 0 to 4.5) executed two trials, walking 20 m each, with inertial sensors attached to their right and left shanks. Gait events were identified from the medio-lateral angular velocity, and short bouts of gait data were extracted from each trial, with lengths varying from 3 to 9 gait cycles. Intraclass correlation coefficients (ICCs) evaluate the degree of agreement between the two trials of each participant, according to the number of gait cycles included in the analysis. Results show that short bouts of gait data, including at least six gait cycles of bilateral data, can provide reliable gait measurements for persons with MS, opening new perspectives for gait assessment using fragmented data (e.g., wearable devices, community assessments). Stride time variability and asymmetry, as well as stride velocity variability and asymmetry, should be further explored as digital biomarkers to support the monitoring of symptoms of persons with neurological diseases.

Highlights

  • Gait impairment is highly prevalent in multiple sclerosis (MS), as the decline in neural control affects motor functions, and gait, balance and mobility [1,2]

  • The analysis showed that spatiotemporal gait parameters calculated as the average across gait cycles, and representing bilateral gait collected from inertial sensor data, can reach “excellent” reliability from as few as three gait cycles

  • Our current study demonstrates that wearable sensors, when collecting bilateral lower limb gait data, can be used to quantify gait from short bouts of data collected, and have the potential to provide reliable measures under free-living conditions to capture the fluctuations of symptoms within a day and over longer periods, as complimentary resources to understand impact and progression of the disease

Read more

Summary

Introduction

Gait impairment is highly prevalent in multiple sclerosis (MS), as the decline in neural control affects motor functions, and gait, balance and mobility [1,2]. Objective gait measurements enable the assessment of the quality and performance of gait, including gait variability and asymmetry [3], providing important information to complete the neurological evaluation of persons with MS [4,5]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call